ADAR1 Capital Management reports NextCure common share purchase worth $3.59 million
NXTC•ADAR1 reports open-market purchases in NextCure
ADAR1 Capital Management, a 10% owner of NextCure, reported open-market purchases totaling 329,153 common shares.
Buying prices clustered around $4.80 to $5.00 per share.
ADAR1’s indirectly held stake rose to 722,419 common shares.
Daniel Schneeberger, manager of ADAR1, was listed as a reporting person on the filing.
